University of Tampa Bay (UTB) — Pharmaceutical Education Reimagined · Est. February 2026
University of Tampa Bay University of Tampa Bay4i · Industry Integrated
Enroll Now →
About UTB

We Built the Institution
the Industry Was Missing.

Incorporated February 2026. Built from the ground up for pharma and biotech professionals — not adapted from a traditional university model.

Explore Programs → Meet Our Schools
Founding Story

How UTB Came to Be

UTB was incorporated in February 2026 as a Delaware nonprofit corporation — not born out of a legacy institution's expansion, but built from the ground up to solve a single, urgent problem in the pharmaceutical industry.

"The pharmaceutical industry is growing faster than its workforce, and traditional education is too slow, too expensive, and too disconnected from real industry needs."

Founded by Ramesh Reddy Putheti (President & CEO) and a seven-member Board of Directors, UTB was designed with one objective: to train the pharmaceutical workforce that the industry actually needs, with the speed, specificity, and accessibility that traditional universities cannot provide.

The 4i Model — Industry First, Integrated Learning, Innovation at the Core, and Institution Built for You — is not a marketing tagline. It is the architectural framework every program, every policy, and every hiring decision is built around.

Accreditation Status →
2026
Year of incorporation · Delaware Nonprofit
7
Board of Directors
Governance, oversight, and strategic direction
3
Academic Schools
Pharmaceutical Sciences, Health Innovation & AI, Pharma Business & Regulatory
17
Career Tracks
Across 15 domains and 32 certificates
$199
Per Credit Hour
vs. $50,000–$150,000 for traditional university programs
The Problem We're Solving

The $370 Billion Problem

The pharmaceutical industry's workforce gap is not a future risk — it's a current crisis. UTB was founded to close it.

36%
Cannot Hire Process Development Staff

Of biopharma facilities are unable to fill critical process development roles — a gap that costs millions in delayed production and missed timelines.

28%
Struggle with Downstream Personnel

Nearly a third of facilities cannot find qualified downstream production personnel, slowing biologic manufacturing timelines industry-wide.

27%
Lack Sufficient Process Engineers

Process engineering shortfalls are directly limiting scale-up capacity across the entire US biopharma sector at a critical moment of expansion.

$370B
Committed to US Biomanufacturing

Record investment in US biomanufacturing infrastructure — but without the trained workforce to execute, the expansion stalls before it starts.

73%
Say Urgent Training Is Needed

Of advanced therapy experts say urgent, specialized training is needed NOW — not in two to four years when a traditional degree would be completed.

2–4yr
Traditional Degree Timeline

$50,000–$150,000. Outdated curriculum. Fixed schedules. The traditional university model was not designed for the pharma workforce crisis of 2026.

Our Philosophy

The 4i Institution

Four principles that define every decision UTB makes — from curriculum design to admissions to pricing.

I
Industry First

Every curriculum is co-developed with active practitioners — not adapted from academic research. If industry doesn't need it, we don't teach it. If industry urgently needs it, we build it first.

I
Integrated Learning

Theory and practice are woven together in every module. UTB graduates are ready from day one — not after a 6-month ramp-up period to learn what the industry actually looks like.

I
Innovation at the Core

AI, digital health, and advanced therapeutics are not electives — they are built into every program. UTB graduates understand where the industry is going, not just where it has been.

I
Institution Built for You

Online. Rolling admissions. $199 per credit. Designed for working professionals who cannot pause their careers for two to four years to get the education they need.

Core Values

Seven Values. One Standard.

These are not aspirational statements. They are operational principles that govern how UTB builds curriculum, hires faculty, and serves students.

01
Innovation Without Limits

Challenging the status quo in education delivery, curriculum design, and technology integration without compromise.

02
Human Touch

Technology enables — people transform. Every student interaction is designed to be personal, responsive, and genuinely helpful.

03
Industry-Integrated

The pharmaceutical industry is our partner, not our audience. We build with the industry, not just for it.

04
Transformative Access

$199 per credit. Rolling admissions. Online delivery. World-class pharma education accessible to every qualified professional regardless of geography or income.

05
Integrity Without Compromise

Academic rigor, ethical conduct, and full transparency in everything from accreditation status to refund policies.

06
Global Community

Pharma is a global industry. UTB is a global institution — with students, faculty, and partners across every major market.

07
Excellence as a Standard

Not as a marketing claim. Excellence is the floor, not the ceiling — in curriculum quality, student outcomes, and institutional governance.

Leadership

The People Behind UTB

UTB is led by practitioners, governed by an independent board, and built by people who have spent careers inside the pharmaceutical industry.

PR
PR Reddy
President & CEO

Founder of UTB and driving force behind the 4i institutional model. PR brings deep expertise in pharmaceutical sciences and a commitment to transforming how the industry develops its workforce. President & CEO since founding, February 2026.

CR
N Charan Reddy
Treasurer

UTB's Treasurer and financial steward. Responsible for fiscal governance, financial planning, and ensuring the institution operates with full financial transparency. Board member since founding.

🧪
School of Pharmaceutical Sciences
Dean — To Be Appointed

Seeking an active industry practitioner with deep expertise in biopharma manufacturing and quality systems.

Apply to Lead This School →
🤖
School of Health Innovation & AI
Dean — To Be Appointed

Seeking a leader at the intersection of AI, digital therapeutics, and health technology innovation.

Apply to Lead This School →
📊
School of Pharma Business & Regulatory
Dean — To Be Appointed

Seeking a senior practitioner with expertise in regulatory affairs, pharma business, and commercialization.

Apply to Lead This School →
7
Board of Directors
7-Member Governing Board

UTB's seven-member Board of Directors provides governance, oversight, and strategic direction for the institution. Board composition reflects expertise in pharmaceutical sciences, healthcare, education, law, and finance. Names will be published upon formal appointment.

Accreditation Status

Our Accreditation Journey

⚠️
UTB credits are not yet federally recognized. UTB Inc. is NOT yet accredited. Students should verify credit transferability with their employer or institution before enrolling. See policies.html for the complete accreditation disclosure.
2026
Florida CIE Licensure Application

Initial state licensure application filed with the Florida Commission for Independent Education.

2027
DEAC Candidacy Application

Application submitted to the Distance Education Accrediting Commission for candidacy status.

2028
DEAC Candidate Status

Expected achievement of DEAC candidate status following initial review and site evaluation.

2031
Full DEAC Accreditation (Projected)

Projected full DEAC accreditation, subject to satisfactory completion of all candidacy requirements.

Explore Our Programs

125+ courses. 15 domains. 17 career tracks. 32 certificates. Built for your pharma career.

Explore Programs → Meet Our Schools